Literature DB >> 22210918

TLR2 activation enhances HIV nuclear import and infection through T cell activation-independent and -dependent pathways.

Jian Ding1, Theresa L Chang.   

Abstract

TLR2 activation plays a crucial role in Neisseria gonorrheae-mediated enhancement of HIV infection of resting CD4(+) T cells. We examined signaling pathways involved in the HIV enhancing effect of TLR2. TLR2 but not IL-2 signals promoted HIV nuclear import; however, both signals were required for the maximal enhancing effect. Although TLR2 signaling could not activate T cells, it increased IL-2-induced T cell activation. Cyclosporin A and IkBα inhibitor blocked TLR2-mediated enhancement of HIV infection/nuclear import. PI3K inhibitor blocked HIV infection/nuclear import and T cell activation and exerted a moderate inhibitory effect on cell cycle progression in CD4(+) T cells activated by TLR2/IL-2. Blockade of p38 signaling suppressed TLR2-mediated enhancement of HIV nuclear import/infection. However, the p38 inhibitor did not have a significant effect on T cell activation or TCR/CD3-mediated enhancement of HIV infection/nuclear import. The cell cycle arresting reagent aphidicolin blocked TLR2- and TCR/CD3-induced HIV infection/nuclear import. Finally, cyclosporin A and IκBα and PI3K inhibitors but not the p38 inhibitor blocked TLR2-mediated IκBα phosphorylation. Our results suggest that TLR2 activation enhances HIV infection/nuclear import in resting CD4(+) T cells through both T cell activation-dependent and -independent mechanisms.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22210918      PMCID: PMC3262879          DOI: 10.4049/jimmunol.1102098

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  56 in total

1.  Nuclear association of a T-cell transcription factor blocked by FK-506 and cyclosporin A.

Authors:  W M Flanagan; B Corthésy; R J Bram; G R Crabtree
Journal:  Nature       Date:  1991-08-29       Impact factor: 49.962

2.  Female to male transmission of human immunodeficiency virus type 1: risk factors for seroconversion in men.

Authors:  D W Cameron; J N Simonsen; L J D'Costa; A R Ronald; G M Maitha; M N Gakinya; M Cheang; J O Ndinya-Achola; P Piot; R C Brunham
Journal:  Lancet       Date:  1989-08-19       Impact factor: 79.321

3.  Role of cytokines and chemokines in the regulation of innate immunity and HIV infection.

Authors:  Massimo Alfano; Guido Poli
Journal:  Mol Immunol       Date:  2005-02       Impact factor: 4.407

4.  Distinct modes of human immunodeficiency virus type 1 proviral latency revealed by superinfection of nonproductively infected cell lines with recombinant luciferase-encoding viruses.

Authors:  B K Chen; K Saksela; R Andino; D Baltimore
Journal:  J Virol       Date:  1994-02       Impact factor: 5.103

5.  HIV-1 entry into quiescent primary lymphocytes: molecular analysis reveals a labile, latent viral structure.

Authors:  J A Zack; S J Arrigo; S R Weitsman; A S Go; A Haislip; I S Chen
Journal:  Cell       Date:  1990-04-20       Impact factor: 41.582

Review 6.  Regulation of HIV-1 gene transcription: from lymphocytes to microglial cells.

Authors:  Olivier Rohr; Céline Marban; Dominique Aunis; Evelyne Schaeffer
Journal:  J Leukoc Biol       Date:  2003-08-11       Impact factor: 4.962

7.  Aphidicolin inhibits DNA synthesis by DNA polymerase alpha and isolated nuclei by a similar mechanism.

Authors:  H Krokan; E Wist; R H Krokan
Journal:  Nucleic Acids Res       Date:  1981-09-25       Impact factor: 16.971

8.  Cofactors in male-female sexual transmission of human immunodeficiency virus type 1.

Authors:  F A Plummer; J N Simonsen; D W Cameron; J O Ndinya-Achola; J K Kreiss; M N Gakinya; P Waiyaki; M Cheang; P Piot; A R Ronald
Journal:  J Infect Dis       Date:  1991-02       Impact factor: 5.226

9.  Human immunodeficiency virus type 1 Gag protein binds to cyclophilins A and B.

Authors:  J Luban; K L Bossolt; E K Franke; G V Kalpana; S P Goff
Journal:  Cell       Date:  1993-06-18       Impact factor: 41.582

10.  TLR2 is expressed on activated T cells as a costimulatory receptor.

Authors:  Mousa Komai-Koma; Louise Jones; Graham S Ogg; Damo Xu; Foo Y Liew
Journal:  Proc Natl Acad Sci U S A       Date:  2004-02-23       Impact factor: 11.205

View more
  12 in total

1.  Strong selection of the TLR2 coding region among the Lagomorpha suggests an evolutionary history that differs from other mammals.

Authors:  Fabiana Neves; Ana Águeda-Pinto; Ana Pinheiro; Joana Abrantes; Pedro J Esteves
Journal:  Immunogenetics       Date:  2019-03-14       Impact factor: 2.846

2.  Toll-Like Receptor 2 Ligation Enhances HIV-1 Replication in Activated CCR6+ CD4+ T Cells by Increasing Virus Entry and Establishing a More Permissive Environment to Infection.

Authors:  Jean-François Bolduc; Michel Ouellet; Laurent Hany; Michel J Tremblay
Journal:  J Virol       Date:  2017-01-31       Impact factor: 5.103

Review 3.  Modulation of HIV transmission by Neisseria gonorrhoeae: molecular and immunological aspects.

Authors:  Gary A Jarvis; Theresa L Chang
Journal:  Curr HIV Res       Date:  2012-04       Impact factor: 1.581

4.  Hepatitis C virus core protein enhances HIV-1 replication in human macrophages through TLR2, JNK, and MEK1/2-dependent upregulation of TNF-α and IL-6.

Authors:  Gokul Swaminathan; Daniel Pascual; Germaine Rival; Renzo Perales-Linares; Julio Martin-Garcia; Sonia Navas-Martin
Journal:  FEBS Lett       Date:  2014-08-14       Impact factor: 4.124

5.  A virus-packageable CRISPR screen identifies host factors mediating interferon inhibition of HIV.

Authors:  Molly OhAinle; Louisa Helms; Jolien Vermeire; Ferdinand Roesch; Daryl Humes; Ryan Basom; Jeffrey J Delrow; Julie Overbaugh; Michael Emerman
Journal:  Elife       Date:  2018-12-06       Impact factor: 8.140

6.  TLR1/2 Agonist Enhances Reversal of HIV-1 Latency and Promotes NK Cell-Induced Suppression of HIV-1-Infected Autologous CD4+ T Cells.

Authors:  Siqin Duan; Xinfeng Xu; Jinshen Wang; Liwen Huang; Jie Peng; Tao Yu; Yang Zhou; Kui Cheng; Shuwen Liu
Journal:  J Virol       Date:  2021-08-10       Impact factor: 5.103

7.  Mycobacterium tuberculosis complex enhances susceptibility of CD4 T cells to HIV through a TLR2-mediated pathway.

Authors:  Seema M Thayil; Ya-Chi Ho; Robert C Bollinger; Joel N Blankson; Robert F Siliciano; Petros C Karakousis; Kathleen R Page
Journal:  PLoS One       Date:  2012-07-23       Impact factor: 3.240

8.  HIV-1 Structural Proteins Serve as PAMPs for TLR2 Heterodimers Significantly Increasing Infection and Innate Immune Activation.

Authors:  Bethany M Henrick; Xiao-Dan Yao; Kenneth Lee Rosenthal
Journal:  Front Immunol       Date:  2015-08-19       Impact factor: 7.561

9.  Anti-HIV activity of human defensin 5 in primary CD4+ T cells under serum-deprived conditions is a consequence of defensin-mediated cytotoxicity.

Authors:  Jian Ding; Carley Tasker; Kimyata Valere; Tiina Sihvonen; Dante B Descalzi-Montoya; Wuyuan Lu; Theresa L Chang
Journal:  PLoS One       Date:  2013-09-25       Impact factor: 3.240

10.  Mycobacterial phosphatidylinositol mannoside 6 (PIM6) up-regulates TCR-triggered HIV-1 replication in CD4+ T cells.

Authors:  Myriam E Rodriguez; Candace M Loyd; Xuedong Ding; Ahmad F Karim; David J McDonald; David H Canaday; Roxana E Rojas
Journal:  PLoS One       Date:  2013-11-25       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.